News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

April

7

electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD

ROCKAWAY, N.J., April 7, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine...

21

Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”)

ROCKAWAY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”),...

19

electroCore Donates gammaCore Sapphire for Real World Evaluation of nVNS in Trauma Among Israelis

ROCKAWAY, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine...

14

electroCore, Inc. Provides Update on nVNS to Treat Post Traumatic Stress Disorder

ROCKAWAY, NJ, Dec. 14, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic...

Recent developments

News

April

7

electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD

January

21

Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”)

November

19

electroCore Donates gammaCore Sapphire for Real World Evaluation of nVNS in Trauma Among Israelis

December

14

electroCore, Inc. Provides Update on nVNS to Treat Post Traumatic Stress Disorder